![Laurie Stelzer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Laurie Stelzer
Président chez
PMV PHARMACEUTICALS, INC.
Fortune : - $ au 31/05/2026
Profil
Ms. Laurie D.
Stelzer is an Independent Director at MBX Biosciences, Inc., an Independent Non-Executive Director at Sionna Therapeutics, Inc., an Independent Director at Spyre Therapeutics, Inc. and a Chairman at PMV Pharmaceuticals, Inc. She is on the Board of Directors at MBX Biosciences, Inc., Sionna Therapeutics, Inc. and Spyre Therapeutics, Inc. Ms. Stelzer was previously employed as a Chief Financial Officer by Kailera Therapeutics, Inc., a Chief Financial Officer by Orna Therapeutics, Inc., a Chief Financial Officer by ReNAgade Therapeutics, Inc., a Chief Financial Officer by Mirati Therapeutics, Inc., a Chief Financial Officer & Executive Vice President by Arena Pharmaceuticals, Inc., an Independent Non-Executive Director by Surface Oncology, Inc., a Chief Financial Officer & Senior Vice President by Halozyme Therapeutics, Inc., a Senior VP-Finance & Head-Investor Relations by Shire, Inc., a Treasurer & Head-Global Accounting by Amgen, Inc., and a Senior VP-Finance & Head-Investor Relations by Shire Plc.
She also served on the board at Longboard Pharmaceuticals, Inc. She received her undergraduate degree from Arizona State University and an MBA from UCLA Anderson School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 04/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
| 04/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
-.--% | 17/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| 17/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
| 27/05/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Laurie Stelzer
| Sociétés | Poste | Début |
|---|---|---|
| PMV PHARMACEUTICALS, INC. | Président | 04/06/2026 |
| SPYRE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 27/11/2023 |
| SIONNA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 08/11/2024 |
| MBX BIOSCIENCES, INC. | Directeur/Membre du Conseil | 20/01/2026 |
Anciens postes connus de Laurie Stelzer
| Sociétés | Poste | Fin |
|---|---|---|
Orna Therapeutics, Inc.
 Orna Therapeutics, Inc. BiotechnologyHealth Technology Develops RNA therapeutics | Directeur Financier/CFO | 01/01/2025 |
Renagade Therapeutics, Inc.
 Renagade Therapeutics, Inc. BiotechnologyHealth Technology Develops proprietary delivery technologies to unlock previously inaccessible cells | Directeur Financier/CFO | 01/05/2024 |
| MIRATI THERAPEUTICS | Directeur Financier/CFO | 08/09/2023 |
| SURFACE ONCOLOGY, INC. | Directeur/Membre du Conseil | 08/09/2023 |
Formation de Laurie Stelzer
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
56
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Health Technology |
Halozyme Therapeutics, Inc.
 Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Spyre Therapeutics, Inc.
 Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
Arizona State University
 Arizona State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCLA Anderson School of Management
 UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PMV Pharmaceuticals, Inc.
 PMV Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in discovery and development of small molecule, tumor-agnostic therapies targeting p53 | Health Technology |
Surface Oncology, Inc.
 Surface Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage immuno-oncology company that develops cancer therapies | Health Technology |
Shire, Inc.
 Shire, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
MBX Biosciences, Inc.
 MBX Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company focused on discovery and development of novel precision peptide therapies for endocrine & metabolic disorders | Health Technology |
Orna Therapeutics, Inc.
Orna Therapeutics, Inc. BiotechnologyHealth Technology Develops RNA therapeutics | Health Technology |
Sionna Therapeutics, Inc.
 Sionna Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for CF and rare diseases | Health Technology |
Longboard Pharmaceuticals, Inc.
 Longboard Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for neurological diseases | Health Technology |
Renagade Therapeutics, Inc.
Renagade Therapeutics, Inc. BiotechnologyHealth Technology Develops proprietary delivery technologies to unlock previously inaccessible cells | Health Technology |
Choisissez Zonebourse 
